<status value="active" /> <date value="2019-06-24T12:52:06.7604872+00:00" /> <publisher value="National Comprehensive Cancer Network, Inc." /> <description value="The sections of a Chemotherapy Order Template." /> <purpose value="NCCN Templates are structured into several sections, and a template note can belong to one of these sections. For example, the note might be contained within the 'Supportive Care - Premedications' section or the 'Monitoring and Hold Parameters' section of the template." /> <caseSensitive value="true" /> <valueSet value="http://ots.nccn.org/hl7/fhir/ValueSet/sections-ValueSet" /> <content value="complete" /> <concept> <code value="chemotherapyRegimen" /> <display value="Chemotherapy Regimen" /> <definition value="The 'Chemotherapy Regimen' section of the template contains cycle and chemotherapy dosing information. After header information, this is the first section of the template." /> </concept> <concept> <code value="relatedTemplateNote" /> <display value="Related Template Note" /> <definition value="The 'Related Template Note' section of the template contains informational notes about linked regimens. This often occurs for linker regimens with multiple courses. If a 'Related Template Note' exists, it will appear immediately before the 'Supportive Care' section of the template." /> </concept> <concept> <code value="supportiveCarePremedications" /> <display value="Supportive Care - Premedications" /> <definition value="The 'Supportive Care - Premedications' section of the template contains information about premedication(s) given to a patient before chemotherapy, usually meant to avert side effects or hypersensitivity reactions (such as allergic reactions)." /> </concept> <concept> <code value="supportiveCareAntiemeticTherapy" /> <display value="Supportive Care - Antiemetic Therapy" /> <definition value="The 'Supportive Care - Antiemetic Therapy' section of the template is intended to provide an overview of the treatment principles for preventing chemotherapy-induced or RT-induced vomiting and nausea, and recommendations for antiemetic prophylaxis according to the emetogenic potential of anti-tumor therapies. See https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf and https://www.nccn.org/professionals/OrderTemplates/PDF/Appendix_D.pdf for more information." /> </concept> <concept> <code value="supportiveCareMyeloidGrowthFactor" /> <display value="Supportive Care - Myeloid Growth Factor" /> <definition value="The 'Supportive Care - Myeloid Growth Factor' section of the template is intended to provide information on MGFs that are primarily used to reduce the incidence of neutropenia. See https://www.nccn.org/professionals/physician_gls/pdf/myeloid_growth.pdf and https://www.nccn.org/professionals/OrderTemplates/PDF/appendix_C.pdf for more information." /> </concept> <concept> <code value="supportiveCareOtherSupportiveTherapy" /> <display value="Supportive Care - Other Supportive Therapy" /> <definition value="The 'Supportive Care - Other Supportive Therapy' section of the template contains all other Supportive Care notes that do not relate to Premedications, Antiemetic Therapy, or Myeloid Growth Factor." /> </concept> <concept> <code value="monitoringAndHoldParameters" /> <display value="Monitoring and Hold Parameters" /> <definition value="The 'Monitoring and Hold Parameters' section of the template contains information on what a clinician should observe during administration of the regimen, such as CBCs or ejection fraction." /> </concept> <concept> <code value="safetyParametersAndSpecialInstructions" /> <display value="Safety Parameters and Special Instructions" /> <definition value="The 'Safety Parameters and Special Instructions' section of the template contains information on patient safety concerns that could arise during the course of administration of the regimen, such as whether an agent is a vesicant or needs to be taken with food." /> </concept> </CodeSystem>